Valuation: Kintor Pharmaceutical Limited

Market Cap 723M 839M 107M 93.06M 86.62M 79.53M 150M 10.22B 153M 1.02B 401M 5.09B 402M 393M 17.06B P/E 2024
-2.53x
P/E 2025 -3.96x
Enterprise Value 777M 902M 115M 99.99M 93.07M 85.45M 161M 10.98B 164M 1.1B 431M 5.47B 432M 423M 18.33B EV / Sales 2024
75,794,130x
EV / Sales 2025 28,245,180x
Free-Float
83.02%
Yield 2024 *
-
Yield 2025 -
1 day+3.66%
1 week+0.59%
1 month-10.99%
3 months-40.14%
6 months-39.72%
Current year-13.27%
1 week 1.61
Extreme 1.61
1.77
1 month 1.61
Extreme 1.61
2.12
Current year 1.61
Extreme 1.61
4.7
1 year 1.61
Extreme 1.61
4.7
3 years 0.79
Extreme 0.79
4.7
5 years 0.79
Extreme 0.79
89
10 years 0.79
Extreme 0.79
89
Manager TitleAgeSince
Chief Executive Officer 64 23/03/2009
Director of Finance/CFO 49 13/04/2023
Chief Tech/Sci/R&D Officer 49 31/08/2020
Director TitleAgeSince
Chairman 64 23/03/2009
Director/Board Member 61 11/08/2019
Director/Board Member 62 11/08/2019
Date Insider Type Main position Quantity % Market Cap.
17/07/26 Other

Chief Executive Officer

145,000 0.0291%
23/01/26 Other

Chief Executive Officer

150,000 0.0301%
22/01/26 Other

Chief Executive Officer

300,000 0.0602%
Change 5-day change 1-year change 3-year change Capi.($)
+3.66%+0.59%-33.59%-57.50% 107M
+2.35%+2.74%+33.41%+79.20% 56.54B
-0.21%-7.38%+25.34%+63.02% 53.6B
-2.44%+1.40%-15.74%-16.80% 22.91B
-2.85%-7.78%-8.09%+346.36% 21.37B
+2.49%-0.92%+20.31%-12.15% 20.27B
+0.79%-1.06%+29.29%-33.32% 17.56B
+0.58%-5.88%+16.30%+540.37% 14.75B
-5.25%-4.23%+46.41%+169.05% 13.33B
+3.41%-6.61%+163.08%+280.43% 13.53B
Average +0.25%-3.35%+27.67%+135.86% 23.4B
Weighted average by Cap. +0.23%-2.96%+28.64%+119.90%

Financials

2024 2025
Net sales 5 5.8 0.74 0.64 0.6 0.55 1.04 70.66 1.05 7.06 2.77 35.18 2.78 2.72 117.96 32.68 37.94 4.84 4.21 3.91 3.59 6.79 461.87 6.89 46.15 18.11 229.94 18.17 17.77 771.02
Net income -155M -180M -22.99M -19.99M -18.6M -17.08M -32.25M -2.19B -32.75M -219M -86.06M -1.09B -86.34M -84.44M -3.66B -200M -232M -29.62M -25.75M -23.97M -22.01M -41.56M -2.83B -42.2M -283M -111M -1.41B -111M -109M -4.72B
Net Debt -15.68M -18.2M -2.32M -2.02M -1.88M -1.72M -3.26M -222M -3.31M -22.14M -8.69M -110M -8.72M -8.53M -370M 53.86M 62.53M 7.97M 6.93M 6.45M 5.92M 11.19M 761M 11.36M 76.05M 29.85M 379M 29.95M 29.29M 1.27B
Logo Kintor Pharmaceutical Limited
Kintor Pharmaceutical Ltd is an investment holding company primarily engaged in the research and development of innovative medicine products. The Company's products are dedicated to addressing disease areas that have not met clinical needs, and its pipeline mainly covers indications of dermatology (such as androgenetic alopecia, acne vulgaris) and indications of tumors. The Company has two core drugs in the dermatology field, KX-826 and GT20029. The Company's other disease areas include metastatic castration-resistant prostate cancer (mCRPC), liver cancer, idiopathic pulmonary fibrosis, malignant blood diseases and various solid tumors.
Employees
123
Date Price Change Volume
31/07/26 HK$1.700 +3.66% 569,000
30/07/26 HK$1.640 -1.20% 227,000
29/07/26 HK$1.660 +1.84% 475,500
28/07/26 HK$1.630 -4.68% 650,500
27/07/26 HK$1.710 +1.18% 462,000

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 9939 Stock